rs200239986
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_032043.3(BRIP1):āc.2854A>Gā(p.Ile952Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032043.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250782Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135566
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461322Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726946
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:3
Curator: Arleen D. Auerbach. Submitter to LOVD: Yukihide Momozawa. -
Variant summary: BRIP1 c.2854A>G (p.Ile952Val) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 250782 control chromosomes, predominantly at a frequency of 0.00054 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 9 fold of the estimated maximal expected allele frequency for a pathogenic variant in BRIP1 causing Hereditary Breast And Ovarian Cancer Syndrome phenotype (6.3e-05). c.2854A>G has been reported in the literature in individuals affected with breast cancer or prostate cancer (Kim_2016, Momozawa_2019). These reports do not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. The following publications have been ascertained in the context of this evaluation (PMID: 26790966, 31214711). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 232950). Based on the evidence outlined above, the variant was classified as likely benign. -
- -
- -
Familial cancer of breast Uncertain:3
- -
- -
This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. -
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
- -
The p.I952V variant (also known as c.2854A>G), located in coding exon 18 of the BRIP1 gene, results from an A to G substitution at nucleotide position 2854. The isoleucine at codon 952 is replaced by valine, an amino acid with highly similar properties. This alteration has been detected in 2/235 high-risk Korean breast cancer patients who previously tested negative for mutations in the BRCA1/2 genes (Kim H et al. Cancer Res Treat. 2016 Jul;48:955-61). This alteration has also been reported in a head and neck squamous cell carcinoma cancer patient from a cohort of 4034 cancer cases from The Cancer Genome Atlas (Lu C et al. Nat Commun. 2015 Dec 22;6:10086). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Familial cancer of breast;C1836860:Fanconi anemia complementation group J Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 952 of the BRIP1 protein (p.Ile952Val). This variant is present in population databases (rs200239986, gnomAD 0.05%). This missense change has been observed in individual(s) with breast cancer, head and neck cancer, biliary tract cancer, and prostate cancer (PMID: 26689913, 26790966, 31214711, 36243179). ClinVar contains an entry for this variant (Variation ID: 232950). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt BRIP1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Fanconi anemia complementation group J Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Ovarian neoplasm;C1836860:Fanconi anemia complementation group J Uncertain:1
- -
not provided Uncertain:1
In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25589003, 26790966, 26689913, 26709662, 29338689, 31214711, 35681111, 11301010, 32566746, 36243179, 37900835) -
Hereditary breast ovarian cancer syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at